Hi-Tech Pharmacal Co. has received Food and Drug Administration for levetiracetam oral solution 100mg/ml, an anti-seizure medication.


Hi-Tech Pharmacal, levetiracetam oral solution, Keppra, Keppra generic, generic version, UCB Pharma, anti-seizure medication, partial onset seizures, epilepsy


















































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Hi-Tech to launch Keppra generic

February 29th, 2012

AMITYVILLE, N.Y. – Hi-Tech Pharmacal Co. has received Food and Drug Administration for levetiracetam oral solution 100mg/ml, an anti-seizure medication.

The company said Wednesday that it plans to ship its product, a generic version of UCB Pharma's Keppra oral solution, by May.

Levetiracetam oral solution had combined brand-name and generic sales of $62 million for the 12 months ended December 2011, according to IMS Health figures cited by Hi-Tech Pharmacal.

The drug is used to treat partial onset seizures in people ages 16 years and older with epilepsy.

Advertisement